Brokerages have assigned a consensus rating of “Moderate Buy” to Relay Therapeutics, Inc. (NASDAQ:RLAY).
According to Bloomberg Ratings, the seven analysts that track Relay Therapeutics, Inc. (NASDAQ:RLAY) have assigned the company a rating of “Moderate Buy” as the company’s …